Home/Events/Isomorphic Labs Raises $5B for Drug Discovery Using AI Models

Isomorphic Labs Raises $5B for Drug Discovery Using AI Models

Confirmed
Confidence
90%
Impact: 80%
Updated 1d ago

Consensus Brief

Isomorphic Labs, an AI drug-discovery platform spun out of Google’s DeepMind, has raised $5 billion in a Series C funding round to advance its drug candidates to clinical trials. The funding was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and existing investors including Alphabet's GV and Capital G. The company has reported positive preclinical results in oncology and immunology and aims to expand its drug-design engine.

Sourced from
Primary: TechCrunch

What Changed Since Last Update

1d ago

New corroborating source added: TechCrunch published an update on Tue, 17 No ("Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials").

Claim Ledger

3 claims tracked across sources

Confirmed Fact

Isomorphic Labs raised $5 billion in a Series C funding round.

Confirmed Fact

The company reported positive preclinical results in oncology and immunology.

Confirmed Fact

Demis Hassabis left his position as head of DeepMind to focus on drug discovery.

Role-Based Impact Analysis